Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

Chemical API market is building core competitive advantages

Chemical API market is building core competitive advantages

2022-08-19

With high R&D investment, Chinese CRO/CDMO companies are able to efficiently undertake outsourced R&D and manufacturing business related to BigPharma and Biotech at home and abroad based on good engineer's bonus

Overview Of The Development Of China's Pharmaceutical Industry 2022

Overview Of The Development Of China's Pharmaceutical Industry 2022

2022-08-18

In recent years, the scale of China's pharmaceutical market has been growing at a relatively fast pace. Data shows that China's pharmaceutical market size from 1,430.4 billion RMB in 2017 to 179.19 billion RMB in 2020

Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022

Analysis of the Chinese Veterinary Drug Raw Material Market in the 33rd Week of 2022

2022-08-18

At present, the veterinary drug raw material market is stable, and themarket inquiries and negotiations are still mainly concentrated on doxycyclinehydrochloride, florfenicol, penicillin potassium industrial salt

The Global API Industry Pattern is Gradually Shifting to China and India

The Global API Industry Pattern is Gradually Shifting to China and India

2022-08-17

Before the 1990s, Europe and the United States were the most important API production areas in the world, with large-scale industries and advanced technology.

FDA Issues Drug Statement, Merck's Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen

FDA Issues Drug Statement, Merck's Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen

2022-08-16

Recently, the US Food and Drug Administration (FDA) official website issued a drug statement: The FDA recently found the nitrosamine impurity Nitroso-STG-19 (NTTP) in some samples of the type 2 diabetes drug sitagliptin.

Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use

Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use

2022-08-12

On August 2, 2022, Hengrui Medicine issuedan announcement that the company received the approval and issuance of the"Drug Clinical Trial Approval Letter" for HRS-4642 injection from theState Food and Drug Administration.

Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)

Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(2)

2022-08-12

Sulfonamide products were generally in a low-key and weak state in the first half of this year, which was greatly affected by the market conditions of pig raising. Inquiries and transactions of some products decreased significantly.

Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)

Analysis of China's Veterinary Drug Raw Material Market in the 32nd Week of 2022(1)

2022-08-12

Doxycycline hydrochloride, the market price is 570-590. In July, the price increased by more than 100 yuan, up 26.1% month-on-month.

Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue

Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue

2022-08-09

According to Biohaven's financial report, the double-acting migraine drug rimegepant (trade name: Nurtec) has sales revenue of US$318 million in the first half of this year

2022H1: Top 10 Best-Selling Drugs in the World

2022H1: Top 10 Best-Selling Drugs in the World

2022-08-05

With the release of the semi-annual reports of major pharmaceuticalcompanies in 2022, the TOP10 list of the world's best-selling drugs has becomeclear.

Vitamin Market Analysis

Vitamin Market Analysis

2022-08-02

Recently, market inquiries have been weak, and the market has a strong wait-and-see mood. Mainstream factories frequently release news of production shutdowns.

Market Analysis of Veterinary Drug Raw Materials

Market Analysis of Veterinary Drug Raw Materials

2022-08-02

Penicillin Potassium Industrial Salt - The market capacity and supply are relatively concentrated. Mainstream factories have raised their quotations, attracting high attention

Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing

Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing

2022-08-02

On July 12, 2022, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd.

Upadatinib's launch accelerated: Crohn's disease has simultaneously submitted marketing applications in FDA&EMA

Upadatinib's launch accelerated: Crohn's disease has simultaneously submitted marketing applications in FDA&EMA

2022-07-29

On July 27, AbbVie announced that it had submitted to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for upadacitinib (trade name Rinvoq, 45mg [induction dose] and 15mg and 30 mg [maintenance dose])

Progesterone Market Potential is Huge

Progesterone Market Potential is Huge

2022-07-25

Progesterone, a steroid hormone synthesized by the placenta, ovaries and adrenal glands, is essential for reproductive function and regulation of the menstrual cycle

Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022

Analysis of the Domestic Veterinary Drug Raw Material Market in the 28th Week of 2022

2022-07-14

Sulfonamide products are affected by the breeding market, and the overall price has fallen

Market Analysis of Cephalosporins and Penicillins

Market Analysis of Cephalosporins and Penicillins

2022-07-14

Ceftiofur sodium, ceftiofur hydrochloride, cephalosporins fell as a whole, the average market transaction price, ceftiofur sodium 1860, down 18.1% year-on-year; ceftiofur hydrochloride 1380, down 20.0% year-on-year

AbbVie Ends An Alzheimer's Immunotherapy Collaboration with Alector

AbbVie Ends An Alzheimer's Immunotherapy Collaboration with Alector

2022-07-11

AbbVie has decided to terminate a collaboration focused on the development of Alzheimer's disease treatment AL003, Alector disclosed in a filing with the U.S. Securities and Exchange Commission a few days ago.

Oseltamivir is Gone, and the Pattern of Anti-influenza Drugs is Reversed!

Oseltamivir is Gone, and the Pattern of Anti-influenza Drugs is Reversed!

2022-06-23

The latest weekly influenza report of the National Influenza Center on June 17 (6.6-6.12) showed that the proportion of influenza-like cases (ILI%) among outpatient cases reported by sentinel hospitals in southern provinces was 5.8%

Market Comparison Before and after the 3rd Batch of Nationally Sourced Hypoglycemic Drug Metformin

Market Comparison Before and after the 3rd Batch of Nationally Sourced Hypoglycemic Drug Metformin

2022-06-23

As a well-known hypoglycemic drug, metformin plays an important role in the field of diabetes treatment. It is the widest and largest variety in the field of diabetes in terms of its scope of use and scale.

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message